VAD Chemotherapy Versus Bortezomib Containing Regimens As Remission Induction For ASCT in Multiple Myeloma: A Single Center Experience

Background: Complete response (CR) and very good partial response (VGPR) are targeted with pre-ASCT induction regimens in patients by diagnosed multiple myeloma (MM), who are candidates for ASCT. In this study, it was aimed to compare the response and survival evaluations of cases who underwent indu...

תיאור מלא

מידע ביבליוגרפי

Principais autores:	Aysun Senturk Yikilmaz, Sema Akinci, Sule Mine Bakanay, İmdat Dilek
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	Tehran University of Medical Sciences 2020-10-01
סדרה:	International Journal of Hematology-Oncology and Stem Cell Research
נושאים:	Multiple myeloma, VAD, Autologous stem cell transplantation, Bortezomib
גישה מקוונת:	https://ijhoscr.tums.ac.ir/index.php/ijhoscr/article/view/1216
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!